Boston Scientific Corp
BSX105.410USD
+0.490+0.47%
Cierre 08/01, 16:00（ET）Cotizaciones retrasadas 15 min
155.92BCap. mercado
76.73P/E TTM
Más Datos de Boston Scientific Corp Compañía
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
Información de la empresa
Símbolo de cotizaciónBSX
Nombre de la empresaBoston Scientific Corp
Fecha de salida a bolsaMay 19, 1992
Fundada en1979
Director ejecutivoMr. Michael F. (Mike) Mahoney
Número de empleados53000
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 19
Dirección300 Boston Scientific Way
CiudadMARLBOROUGH
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal01752-1234
Teléfono15086834000
Sitio Webhttps://www.bostonscientific.com/en-US/Home.html
Símbolo de cotizaciónBSX
Fecha de salida a bolsaMay 19, 1992
Fundada en1979
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.75M
-3.25%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
+3.95%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
37.98K
+5.88%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
37.02K
+5.96%
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
33.45K
+6.64%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
5.63K
+58.67%
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
2.08K
-58.23%
Mr. Arthur Crosswell Butcher
Mr. Arthur Crosswell Butcher
Executive Vice President, Group President, MedSurg and Asia Pacific
Executive Vice President, Group President, MedSurg and Asia Pacific
--
--
Mr. Edward J. Ludwig
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
--
--
Ms. Meghan Scanlon
Ms. Meghan Scanlon
Senior Vice President and President - Urology
Senior Vice President and President - Urology
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.75M
-3.25%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
+3.95%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
37.98K
+5.88%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
37.02K
+5.96%
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
33.45K
+6.64%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
5.63K
+58.67%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Electrophysiology
730.00M
15.66%
Interventional Cardiology Therapies
697.00M
14.95%
Endoscopy
673.00M
14.43%
Peripheral Interventions
656.00M
14.07%
Urology
633.00M
13.57%
Other
1.27B
27.32%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
2.96B
63.48%
EMEA (Europe, Middle East and Africa)
846.00M
18.14%
Asia Pacific
701.00M
15.03%
Latin America and Canada
155.00M
3.32%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Electrophysiology
730.00M
15.66%
Interventional Cardiology Therapies
697.00M
14.95%
Endoscopy
673.00M
14.43%
Peripheral Interventions
656.00M
14.07%
Urology
633.00M
13.57%
Other
1.27B
27.32%
Estadísticas de accionistas
Actualizado: jue., 24 de jul
Actualizado: jue., 24 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
9.05%
Fidelity Management & Research Company LLC
7.94%
BlackRock Institutional Trust Company, N.A.
5.26%
State Street Global Advisors (US)
4.36%
PRIMECAP Management Company
2.47%
Other
70.92%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
9.05%
Fidelity Management & Research Company LLC
7.94%
BlackRock Institutional Trust Company, N.A.
5.26%
State Street Global Advisors (US)
4.36%
PRIMECAP Management Company
2.47%
Other
70.92%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
52.58%
Investment Advisor/Hedge Fund
28.08%
Hedge Fund
3.98%
Pension Fund
2.91%
Research Firm
2.45%
Bank and Trust
1.71%
Sovereign Wealth Fund
1.54%
Private Equity
0.20%
Insurance Company
0.19%
Other
6.37%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
2738
1.39B
93.92%
-1.01M
2025Q1
2744
1.39B
93.81%
-5.31M
2024Q4
2559
1.38B
93.61%
+1.09M
2024Q3
2417
1.37B
92.76%
-24.32M
2024Q2
2341
1.37B
93.29%
-18.17M
2024Q1
2227
1.37B
93.23%
-40.14M
2023Q4
2171
1.39B
94.95%
-25.34M
2023Q3
2110
1.39B
95.17%
-6.29M
2023Q2
2081
1.38B
95.67%
-15.63M
2023Q1
2012
1.36B
94.85%
-23.81M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
133.95M
9.05%
+1.70M
+1.28%
Mar 31, 2025
Fidelity Management & Research Company LLC
117.45M
7.94%
-3.75M
-3.09%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
77.81M
5.26%
+1.08M
+1.41%
Mar 31, 2025
State Street Global Advisors (US)
64.48M
4.36%
+514.79K
+0.80%
Mar 31, 2025
PRIMECAP Management Company
36.50M
2.47%
-432.72K
-1.17%
Mar 31, 2025
Wellington Management Company, LLP
33.20M
2.24%
-2.97M
-8.21%
Mar 31, 2025
Geode Capital Management, L.L.C.
31.80M
2.15%
+1.18M
+3.84%
Mar 31, 2025
Capital World Investors
28.56M
1.93%
+658.82K
+2.36%
Mar 31, 2025
Managed Account Advisors LLC
21.29M
1.44%
+3.60M
+20.36%
Mar 31, 2025
The Bollard Group, LLC
20.49M
1.39%
-242.40K
-1.17%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: hace 12 horas
Actualizado: hace 12 horas
Nombre
Proporción
iShares U.S. Medical Devices ETF
11.22%
Goldman Sachs Future Health Care Equity ETF
8.79%
Invesco Dorsey Wright Healthcare Momentum ETF
5.45%
NYLI Healthy Hearts ETF
5.03%
JPMorgan Healthcare Leaders ETF
4.31%
Tema Heart & Health ETF
3.68%
iShares Health Innovation Active ETF
3.61%
Health Care Select Sector SPDR Fund
3.25%
Proshares Ultra Health Care
3.25%
Knowledge Leaders Developed World ETF
3.23%
Ver más
iShares U.S. Medical Devices ETF
Proporción11.22%
Goldman Sachs Future Health Care Equity ETF
Proporción8.79%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporción5.45%
NYLI Healthy Hearts ETF
Proporción5.03%
JPMorgan Healthcare Leaders ETF
Proporción4.31%
Tema Heart & Health ETF
Proporción3.68%
iShares Health Innovation Active ETF
Proporción3.61%
Health Care Select Sector SPDR Fund
Proporción3.25%
Proshares Ultra Health Care
Proporción3.25%
Knowledge Leaders Developed World ETF
Proporción3.23%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
